Plerixafor API Manufacturers

compare suppliers & get competitive offers

Filters

Reset

Selected filters:

Type
Production region
Qualifications
Country of origin

Producer

Produced in:

India

Established in: 1984

MOQ: -

Employees: 21,650

Diverse portfolio of 180+APIs

1754+ DMF across global markets

1100+ patents filed, and more than 70 own patents granted

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • DMF

  • WC

  • GMP

  • CoA

  • FDA

  • MSDS

  • BSE/TSE

Contact supplier

Replies quickly

Located in:

India
  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • DMF

  • CoA

Contact supplier

Replies slower than most

Located in:

India
  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • DMF

  • CoA

Contact supplier

Replies slower than most

Located in:

India

Producer

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • WC

  • CoA

  • GMP

  • DMF

Located in:

India
  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • DMF

  • CoA

Located in:

India

Producer

  • CoA

  • GMP

  • CEP

  • FDA

  • DMF

  • + 0

All certificates

  • GMP

  • DMF

  • WC

  • CoA

How does it work?

1
Register for free
icon

You can register for free as long as you are registering on behalf of a legal company related to the pharmaceutical industry

2
Start sourcing
icon

Search in the search bar the product that you’re looking for. We’ll show you an overview of all available suppliers. Use the filters to select the relevant suppliers only

3
Send inquiries
icon

Have you found interesting suppliers? Then it’s time to contact them. Use the send inquiry button and send them a message. You can send for each product, 3 inquiries per week

4
Get quotation
icon

Suppliers get notified by Pharmaoffer that they’ve received a new inquiry. They will come back to you with their questions, certificates, and offer in the chat on Pharmaoffer. We will send you an email in case of any news

5
Arrange agreement
icon

Does the supplier meet your quality and commercial requirements? Then you can place the order. Just follow the steps of our order module

Looking for Plerixafor API 110078-46-1?

Description:
Here you will find a list of producers, manufacturers and traders of Plerixafor. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
API | Excipient name:
Plerixafor 
Synonyms:
AMD3100 , Mozobil  
Cas Number:
110078-46-1 
DrugBank number:
DB06809 
Unique Ingredient Identifier:
S915P5499N

About Plerixafor

You can find a short description about Plerixafor here. Plerixafor is a hematopoietic stem cell mobilizer. It is used to stimulate the release of stem cells from the bone marrow into the blood in patients with non-Hodgkin lymphoma and multiple myeloma for the purpose of stimulating the immune system. These stem cells are then collected and used in autologous stem cell transplantation to replace blood-forming cells that were destroyed by chemotherapy. Plerixafor has orphan drug status in the United States and European Union; it was approved by the U.S. Food and Drug Administration on December 15, 2008.

Not sure if this is the exact product you're looking for? Contact the supplier by using the send inquiry button.

Plerixafor is a type of Colony stimulating factors


Colony stimulating factors (CSFs) are a vital subcategory of pharmaceutical active pharmaceutical ingredients (APIs) that play a crucial role in the field of biotechnology and medicine. These specialized proteins are responsible for regulating the growth, development, and function of different types of blood cells, specifically white blood cells known as granulocytes and macrophages.

CSFs are extensively used in the treatment of various medical conditions, such as cancer, bone marrow transplantation, and certain blood disorders, where the production and function of white blood cells are impaired. By stimulating the production and differentiation of these crucial immune cells, CSFs help enhance the body's defense mechanisms against infections, accelerate the recovery process, and reduce the risk of life-threatening complications.

Pharmaceutical companies utilize advanced biotechnological techniques to produce synthetic CSFs or isolate them from natural sources, such as mammalian cell cultures. These API products undergo rigorous purification and quality control processes to ensure their safety, efficacy, and compliance with regulatory standards.

In clinical settings, CSFs are administered through injections, typically subcutaneously or intravenously, under the supervision of healthcare professionals. The dosage and treatment duration vary depending on the specific medical condition being treated and the patient's individual needs.

With their significant impact on immune system function and therapeutic potential, colony stimulating factors hold immense promise in the pharmaceutical industry. Ongoing research and development efforts continue to explore new applications and optimize the production and delivery of these essential pharmaceutical APIs.


Plerixafor (Colony stimulating factors), classified under Hematopoietic Agents


Hematopoietic agents are a category of pharmaceutical active pharmaceutical ingredients (APIs) that play a crucial role in the treatment of various blood disorders and diseases. These agents stimulate the production, maturation, and function of blood cells, particularly those involved in the process of hematopoiesis, which is the formation of new blood cells.

One of the commonly used hematopoietic agents is erythropoietin, a glycoprotein hormone that regulates red blood cell production. It is employed in the treatment of anemia associated with chronic kidney disease, cancer chemotherapy, and certain other conditions. Another important hematopoietic agent is granulocyte colony-stimulating factor (G-CSF), which stimulates the production of white blood cells known as neutrophils. G-CSF is used to prevent infections in patients undergoing chemotherapy and to enhance the recovery of blood cell counts after bone marrow transplantation.

Thrombopoietin receptor agonists are another class of hematopoietic agents that promote the production of platelets, essential for blood clotting. These agents find applications in the management of thrombocytopenia, a condition characterized by low platelet counts.

Hematopoietic agents are typically administered through injections or infusions, and their dosage and frequency vary depending on the specific indication and patient's response. While these agents provide critical therapeutic benefits, their use requires careful monitoring to ensure optimal efficacy and safety.

In conclusion, hematopoietic agents are vital pharmaceutical APIs used to stimulate the production of blood cells and treat various blood disorders. Their use significantly improves patients' quality of life and plays a crucial role in managing hematological conditions.



Plerixafor manufacturers | traders | suppliers

We have 6 companies offering Plerixafor produced in 1 different countries.

Get in contact with the supplier of your choice:

  • Dr. Reddy's from India, product country of origin India
  • Fresenius Kabi Onc. from India, product country of origin India
  • Gland Pharma from India, product country of origin India
  • Hetero Labs from India, product country of origin India
  • Biophore India from India, product country of origin India
  • MSN Labs. from India, product country of origin India

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.